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ABSTRACT
Over 50% of genes in Plasmodium falciparum, the
deadliest human malaria parasite, contain pre-
dicted introns, yet experimental characterization of
splicing in this organism remains incomplete.
We present here a transcriptome-wide charac-
terization of intraerythrocytic splicing events, as
captured by RNA-Seq data from four timepoints
of a single highly synchronous culture. Gene
model-independent analysis of these data in con-
junction with publically available RNA-Seq data
with HMMSplicer, an in-house developed splice site
detection algorithm, revealed a total of 977 new
50 GU-AG 30 and 5 new 50 GC-AG 30 junctions absent
from gene models and ESTs (11% increase to
the current annotation). In addition, 310 alterna-
tive splicing events were detected in 254 (4.5%)
genes, most of which truncate open reading
frames. Splicing events antisense to gene models
were also detected, revealing complex transcrip-
tional arrangements within the parasite’s tran-
scriptome. Interestingly, antisense introns overlap
sense introns more than would be expected
by chance, perhaps indicating a functional relation-
ship between overlapping transcripts or an inher-
ent organizational property of the transcriptome.
Independent experimental validation confirmed
over 30 new antisense and alternative junctions.
Thus, this largest assemblage of new and alternative
splicing events to date in Plasmodium falciparum
provides a more precise, dynamic view of the
parasite’s transcriptome.
INTRODUCTION
Close to one million people every year are killed by
malaria, an infectious disease caused by protozoan para-
sites of the genus Plasmodium (World Malaria Report
2009 http://www.who.int/malaria/world_malaria_report_
2009/en/index.html), of which Plasmodium falciparum is
the deadliest. In efforts to understand the parasite’s
basic biology and discover unique vulnerabilities, several
studies have detailed transcriptome-wide RNA expression
data during various parasite lifestages (1–3). However,
although more than half of the parasite’s genes are pre-
dicted to contain introns (4), no specific transcriptome-
wide analysis of splicing in this organism has been per-
formed to date. Splicing, the mechanism by which intronic
sequences are removed and exonic sequences are joined
together, not only determines the protein coding or func-
tional RNA sequence of a mature transcript but also the
regulatory information included in the transcript.
Alternative splicing adds an additional layer of complexity
by allowing the generation of different mature transcripts
from the same precursor, and is crucial to such diverse
biology as Drosophila sex determination and HIV-1 repli-
cation (5,6). Thus, a transcriptome-wide picture of splicing
and alternative splicing in P. falciparum is crucial for
recognizing the full regulatory, protein encoding and func-
tional RNA encoding complexities of the transcriptome.
Although the molecular mechanism of RNA splicing
remains murky in P. falciparum, it has been well studied
in model organisms. In the classical pathway, two
transesterification steps are catalyzed by the spliceosome,
a large complex of small nuclear ribonucleoproteins
(snRNPs), each containing an snRNA component and a
core set of proteins. snRNAs have been documented in
P. falciparum (7,8), but only one protein component, a
UAP56 homolog, has been definitively identified (9).
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As with splicing components, elucidation of the motifs
guiding splicing also remains incomplete. Typically these
motifs include the 50-splice site (AG|GUAUGU in yeast,
AG|GURAGU in mammals), the branch point sequence
(UACUAAC in yeast, YNYURAY in mammals), the
poly-pyrimidine tract (variable length in both yeast and
mammals) and the 30-splice site (CAG| in yeast, YAG| in
mammals) (10). In P. falciparum, EST data have been used
to generate putative 50 (AR|GUAANW) and 30 (YAG|)
splice site motifs (7). As in most eukaryotes, the first and
last 2 nt of the intron (50 GU-AG 30) are the most consist-
ent markers of intronic sequence. In other organisms, a
minority of introns are marked by non-canonical splice
sites such as 50 GC-AG 30 (recognized by the major
U2-type spliceosome) and 50 AU-AC 30 (recognized by
the minor U12-type spliceosome) (11). Non-canonical
splice sites occur in P. falciparum EST data (12,13) and
have been incorporated into some gene models, yet no
study to date has documented the types of intron
boundaries recognized by the parasite.
Alternative splicing, in which the same precursor tran-
script can give rise to multiple different mature transcripts,
also occurs in the parasite. Although relatively little is
known about splicing in general in P. falciparum, more
than 100 alternative splicing events have been reported
in Plasmodium species since 1991 (14–20). Alternatively
spliced isoforms have also been computationally
predicted, yet lack experimental validation (21).
Recent analyses have shown that transcriptome com-
plexity in many organisms extends beyond alternative
splicing. Dense transcriptional arrangements, such as
overlapping protein-coding genes (in parallel or antiparal-
lel orientation) and natural antisense transcripts (22,23),
now appear to be commonplace rather than anomalous.
Although the functional importance of these arrange-
ments is not yet well understood, some are known to be
important in regulatory relationships between the paired
genes (24). In current P. falciparum gene models, six in-
stances of protein-coding gene overlap are annotated, re-
sulting in one parallel and five antiparallel gene pairs. In
addition, RNA polymerase II has been shown to synthe-
size long antisense transcripts in the parasite (25), and
EST data indicate that at least one of these may be
spliced (12). Short antisense transcripts have also been
described (26).
In this study, RNA-Seq data were generated from four
timepoints in the intraerythrocytic transcriptome of P. fal-
ciparum for the purpose of characterizing splicing in this
organism. Unbiased, gene model-independent splice site
detection within our data set in conjunction with
RNA-Seq data from Otto et al. and Sorber et al. (14,27)
was accomplished using the HMMSplicer algorithm (28),
which was specifically developed to handle the challenging
RNA-Seq data sets generated from the A/T-rich genome
of P. falciparum. A total of 977 new 50 GU-AG 30 and 5
new 50 GC-AG 30 junctions never before documented in
gene models or ESTs were discovered. Further analysis
uncovered alternative splicing events, largely within 254
genes, as well as splicing events antisense to one
another. Antisense events, some of which themselves
displayed alternative splicing, likely indicate a mix of
overlapping annotated genes transcribed from opposite
strands and unannotated transcripts transcribed antisense
to gene models. Unexpectedly, antisense introns overlap
sense gene introns more than would be anticipated by
chance, perhaps indicating some relationship between
overlapping transcripts, or an inherent feature of tran-
scriptome organization. Over 30 antisense and alternative
splicing events were independently experimentally verified,
indicating that the new, alternative and antisense splicing
events elucidated here support a larger, more dynamic
understanding of the parasite’s transcriptome.
MATERIALS AND METHODS
Generation of timepoint samples
3D7 Oxford P. falciparum parasites were grown at 2%
hematocrit in 30T150ml flasks with 50ml of volume
each. Repeat synchronization during peak invasion and
again 12 h later over three consecutive lifecycles
produced 30ml of packed blood containing 11% highly
synchronized late schizont parasites. This starter culture
was allowed to invade 140ml of unparasitized blood in
830ml of culture medium in a 5 l dished bottom bioreactor
(Applikon Inc, Brauwegg, Netherlands). Bioreactor con-
ditions and culture medium were as in Bozdech et al. (1).
After 4 h, the culture was diluted to 5% hematocrit with
3 l of culture medium. Half (50%) of the culture was har-
vested 11 h after invasion (TP1), pelleted and frozen at
80C. Thirty-three percent of the culture was harvested
22 h after invasion (TP2), 10% 33 h after invasion (TP3)
and 7% 44 h after invasion (TP4). Total RNA was
harvested from frozen pellets using Trizol (Invitrogen
Corp., Carlsbad, CA, USA), then poly-A selected using
the Micro FastTrack 2.0 kit (Invitrogen Corp.).
Generation of RNA-Seq libraries
Libraries were generated as in Sorber et al. (27). Briefly,
1.2–1.6mg of polyA-selected RNA was reverse transcribed
using 6bp-EciI-N9 (all primers can be found in
Supplementary Table S1), and second strand cDNA syn-
thesis was carried out with 13-bp-ModSolS-N9. Five
cycles of PCR were done with 6bp-EciI and biotin-
short-Mod-SolS (biotin-short-Mod-PE-SolS for TP1 and
TP2 libraries), followed by binding to Dynal Dynabeads
M-280 (Invitrogen Corp.). Bead-bound material was
digested with EciI, then treated with Antarctic
Phosphatase (New England Biolabs, Ipswich, MA,
USA). Sol-L-NN annealed adapter was ligated onto cut
ends. Five final cycles of PCR were performed on one-
fourth of bead-bound material using Sol primer 1 and
fullModSolS (fullMod-PE-SolS for TP1 and TP2
libraries). Remaining bead-bound material was subjected
to three rounds of Long March using GsuI and the
Sol-L-NN annealed adapter (27). The additional TP4
library sequenced here derived from a fourth Long
March of the thrice-marched library described in Sorber
et al. annealed to the Sol-L-AC-NN adapter (27). Final
PCR on marched sub-libraries was as described for initial
libraries.
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Illumina sequencing of RNA-Seq libraries
For TP1-3, the initial library and the thrice-marched
sub-library were clustered on an Illumina flow cell in
separate lanes (Illumina, Hayward, CA, USA). For
single-end libraries and the first read of paired-end
libraries, Sol-SeqPrimer was used as the sequencing
primer, and PE-SolS-SeqPrimer was used to sequence
the second read of paired-end libraries. Up to 60 single
base extensions were performed with image capture using
an Illumina GA2 sequencer (Illumina; Supplementary
Table S2). The Illumina Pipeline software suite version
0.2.2.6 (Illumina) was utilized for base calling from these
images for TP3 and TP4, and versions 1.3.2 and 1.5.0 were
used to base call TP1 and TP2 images. All primary
sequencing data can be found in the NCBI Short Read
Archive under accession number SRA024324.1.
Analysis pipeline
Raw sequence data from the above timecourse as well as
from Otto et al. and Sorber et al. (14,27) were aggregated
and any barcodes were removed. Reads with greater than
12 nt of adapter sequence, a repeat of A, T, C, G, or AT
longer than 11 nt, or more than 10 nt with a quality scores
5 were discarded. Identical sequences within a timepoint
were compressed to a single sequence read and the reads
were filtered to remove human sequences, as detected by
BLAST against the human genome with an E-value of
1 105 (29).
To gauge overall coverage, the filtered read set
was aligned to the P. falciparum genome, PlasmoDB
version 6.3 (30), by Bowtie version 0.12.1, using default
parameters except that alignment of reads with multiple
matches was disallowed (31). Reads unaligned by Bowtie
were then aligned using BLAT version 34 with a tile size
of 11, a step size of 1, and using an ooc file to filter repeti-
tive sequence (32). Bowtie alignments were combined
with BLAT alignments score 35 to yield the final set
of aligned reads from which coverage statistics were
generated.
To detect exon–exon spanning reads, HMMSplicer
v0.7.0 was run in parallel on the filtered read set against
the P. falciparum genome, PlasmoDB version 6.3 with a
minimum intron size of 5 nt, a maximum intron size of
1000 nt and an anchor size of 6 nt (28). All other param-
eters were left at default values.
Operational definitions for data analysis
To avoid confusion, a specific terminology was used to
refer to specific parts of individual splice junctions and
to classify junctions (Supplementary Figure S1A–D).
For all definitions referencing gene models, a junction
maps to a gene model only if at least one inner
edge falls within the bounding coordinates of the gene
model.
A ‘known junction’ maps to the same pair of inner
boundaries as a splice junction found in PlasmoDBv6.3
gene models or in EST data (Supplementary Figure S1B).
A ‘new junction’ maps to a pair of boundaries not seen in
PlasmoDBv6.3 gene models or in EST data. ‘Canonical
junctions’ map to 50 GU-AG 30 boundaries, while
‘noncanonical junctions’ map to all other possible
boundaries. A ‘junction conflict’ occurs when an inner
edge of one junction falls within the intronic portion of
the other junction such that they must occur in a
mutually exclusive manner (Supplementary Figure S1C).
‘Junction groups’ were built by randomly selecting a
nucleating junction, then searching for all relevant con-
flicting junctions. These junctions were added to the
group and the search was iterated until no new junctions
were appended. ‘Alternate 50- and 30-splice sites’ refers
to splice junctions where both the 50- and 30-splice sites
conflict (Supplementary Figure SC). A splice junction
that conflicts with two or more junctions that themselves
do not conflict is considered a ‘skipped exon’. Although
such instances could instead be interpreted as inde-
pendent alternate 50- and 30-splice sites, skipped exon inter-
pretation is consistent not only with our own independent
experimental validations, but also frequently with gene
models. In an ‘antisense conflict’, two junctions conflict
with boundaries on opposite strands (Supplementary
Figure S1D). However, ‘antisense junctions’ must have at
least one boundary antisense to a gene model. See
Supplementary Materials and Methods for analysis
beyond these categorizations.
Validation of new splicing events
In determining which new splicing events to assess, only
new junctions that conflicted with recovered known junc-
tions were considered, so that each validation had an
internal positive control. In addition, the known isoform
had to be 30 bp longer than the putative new isoform to
ensure a selective restriction digest with size distinguish-
able final PCR products. The top 20 new junctions for
which successful validation schemes could be computa-
tionally designed were picked starting with the highest
scoring new junction for the group above the threshold,
and starting with the highest scoring new junction below
1075 for the group below the threshold.
A biologically independent small-scale timecourse
similar to the Bioreactor timecourse was performed using
highly synchronous 3D7 Oxford parasites. After total
RNA extraction as described above, RNA from each
timepoint was reverse transcribed. For each validation,
cDNA from the lifecycle stage with the highest represen-
tation of the new junction was used in the PCR-restriction
digest-PCR scheme depicted in Figure 2A, with products
column purified between steps. Appropriate primers and
enzymes for each validation are listed in Supplementary
Table S3. Size appropriate final PCR bands were gel
extracted, then TOPO TA cloned (Invitrogen Corp.).
Whole cell PCR products from positive colonies were
sequenced using the BigDye Terminator v3.1 Cycle
Sequencing Kit on an ABI 3130xl Genetic Analyzer (Life
Technologies Corp., Carlsbad, CA, USA). Resulting se-
quences were trimmed for vector and then aligned to the
P. falciparum genome (v6.3) using BLAT (32). See
Supplementary Materials and Methods for additional
details.
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RESULTS
Plasmodium falciparum contains specific orthologs to
splicing factors
In P. falciparum, RNA components of the major U2-type
spliceosome have been detected (7,8), yet protein compo-
nents have not been systematically identified. Using recip-
rocal best hits (RBH) analysis (33) of human and yeast
splicing factors, we identified putative homologs to
spliceosome and spliceosome-associated protein compo-
nents (Table 1) (34–36), the majority of which were most
similar to their human counterparts. However, homologs
of three components of the human spliceosome could not
be identified: SFY2, PPIE and PRP2. PRP2, a DEAH/
D-box ATPase, is ostensibly the most critical of the
three, as it is thought to induce a structural rearrangement
that results in dissociation of the SF3a and b complexes
from the branchpoint, rendering the branchpoint compe-
tent for nucleophilic attack of the 50-splice site (37).
Interestingly, initial analysis returned PF10_0294 as the
closest match in P. falciparum for both human PRP2
and PRP22, though the reciprocal BLAST completing
RBH analysis returned PRP22 as a slightly better match
for PF10_0294 within the human genome (Table 1). PRP2
and PRP22 are both DEAH/D-box proteins involved in
splicing with a high degree of conservation between their
helicase and C-terminal domains. In Sachharomyces
cerevisiae and other related yeast, PRP2 proteins contain
a conserved DC amino acid doublet in their C-terminal
domain that distinguishes them from other closely related
DEAH/D-box ATPases, such as PRP22 (38). Although
RBH analysis points to PF10_0294 as a PRP22
Table 1. Putative P. falciparum splicing and non-sense-mediated decay factor homologs identified by reciprocal best hits analysis with human or
S. cerevisiae sequences
Complex Human/Yeast Pf Homolog Complex Human/Yeast Pf Homolog
snRNP core (stability and
functionofU1, U2, U4
and U5 snRNPs)
SNRPB/SMB1 PF14_0146 U4/U6 (catalytic activation of
spliceosome)
PRPF3/PRP3 MAL13P1.45
SNRPD1/SMD1 PF11_0266 NHP2L1/SNU13 PF11_0250
SNRPD2/SMD2 PFB0865w PRPF4/PRP4 MAL13P1.385a
SNRPD3/SMD3 PFI0475w PRPF31/PRP31 PFD0450c
SNRPE/SME1 MAL13P1.253 PPIH/- PF08_0121b
SNRPF/SMX3 PF11_0280 tri-snRNP (activation of
spliceosome)
SART1/SNU66 PFC1060ca
SNRPG/SMX2 MAL8P1.48 USP39/SAD1 PF13_0096a
U6 core (stability and
function of U6 snRNP)
LSM2/LSM2 PFE1020w SNRNP27/- MAL8P1.71a,b
LSM3/LSM3 PF08_0049 hPrp19/CDC5 (specification of
U5 and U6 interactions
with RNA)
PRPF19/PRP19 PFC0365w
LSM4/LSM4 PF11_0524 CRNKL1/CLF1 PFD0180c
LSM5/LSM5 PF14_0411 CDC5L/CEF1 PF10_0327a
LSM6/LSM6 PF13_0142b ISY1/ISY1 PF14_0688
LSM7/LSM7 PFL0460w BCAS2/SNT309 PFF0695wa,b
NAA38/LSM8 MAL8P1.9b XAB2/SYF1 PFL1735ca
U1 (initial 50-ss
recognition)
SNRNP70/SNP1 MAL13P1.338 PLRG1/PRP46 PFC0100ca
SNRPA/MUD1 MAL13P1.35b SYF2/SYF2 ?
SNRPC/YHC1 PF08_0084 SNW1/PRP45 PFB0875ca
U2 (BP detection) SNRPA1/LEA1 PF13_0362 BUD31/BUD31 PFE1140c
SNRPB2/MSL1 PFI1695c PPIE/- ?
U2-related (BP and poly-Y
recognition)
U2AF1/- PF11_0200b CCDC12/- PF14_0490a
U2AF2/MUD2 PF14_0656b AQR/- PF13_0273a,b
SF1/MSL5 PFF1135w CWC15/CWC15 PF07_0091b
SF3a (stability ofU2-BaP
interaction)
SF3A1/PRP21 PF14_0713a PPIL1/- PFE1430cb
SF3A2/PRP11 PFF0970w Non-snRNP factors (second
step factors) (RNA release)
DHX16/PRP2 PF10_0294?a
SF3A3/PRP9 PFI1215w BAT1/SUB2 PFB0445c
SF3b (stability of U2-BP
interaction)
SF3B1/HSH155 PFC0375c DDX46/PRP5 PFE0430wa
SF3B2/CUS1 PF14_0587 SLU7/SLU7 PFF0500c
SF3B3/RSE1 PFL1680w DHX38/PRP16 MAL13P1.322
SF3B4/HSH49 PF14_0194 CDC40/CDC40 PFL0970w
SF3B5/YSF3 PF13_0296 PRPF18/PRP18 PFI1115c
PHF5A/RDS3 PF10_0179a DHX8/PRP22 PF10_0294?a
SF3B14/- PFL1200cb NMD (detection of nonsense
transcripts)
UPF1/NAM7 PF10_0057
U5 (catalytic activation of
spliceosome)
DDX23/PRP28 PFE0925c UPF2/NMD2 PFI1265wa
CD2BP2/LIN1 PF10_0310a UPF3A/UPF3 ?
EFTUD2/SNU114 PF10_0041b UPF3B/- PF13_0158b
SNRNP200/ BRR2 PFD1060w SR and hnRNP SRSF1/- PFE0865cb
TXNL4A/DIB1 PFL1520w SRSF12/- PFE0160cb
PRPF8/PRP8 PFD0265w PTBP2/- PFF0320cb
PRPF6/PRP6 PF11_0108 SFRS4/- PF10_0217b
SNRNP40/- MAL8P1.43b TRA2B/- PF10_0028a,b
The human or S. cerevisiae factor in bold font represents the best match for the P. falciparum homolog. Homologs of spliceosomal and NMD factors
not found are denoted with question marks, while SR and hnRNP factors not found are not shown. Saccharomyces cerevisiae homologs that do not
reside in the same complex as their human counterparts are italicized.
aPlasmodium falciparum proteins described in PlasmoDB as ‘conserved Plasmodium protein’ or with descriptions that do not reflect involvement in
splicing.
bHomologs identified only by the human sequence.
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homolog, alignment of the C-terminal portion
of PF10_0294 reveals the presence of the DC doublet
signature of PRP2 homologs in yeast (Supplementary
Figure S2). Without biochemical characterization, it is
difficult to determine which role PF10_0294 might play,
and it is possible that it encompasses the activity of both
DEAH/D-box ATPases. Thus, while our RBH analysis is
helpful as a first step in determining players involved
in splicing, careful experimental verification of the exact
roles of these putative homologs is still required to fully
understand how splicing occurs in P. falciparum.
In other eukaryotes, alternative splicing is guided by the
presence or absence of proteins that determine which
splice sites are available to the spliceosome (39). To deter-
mine if P. falciparum has homologs to such proteins,
human arginine/serine-rich (SR) and heterogeneous
nuclear ribonucleoproteins (hnRNP) proteins with docu-
mented roles in alternative splicing were used for best re-
ciprocal hits analysis (40,41). Four SR proteins and one
hnRNP protein returned specific homologs (Table 1).
These homologs likely represent only a fraction of the
proteins that influence splice site selection in P. falcip-
arum, as at least 71 additional proteins contain either an
RNA recognition motif (RRM) or an RNA binding
domain (RBD) according to InterPro (42), and 7 contain
an RS domain according to our own analysis. Many
proteins involved in splice site selection during alternative
splicing utilize one or more of these domains, although
they do not guarantee involvement in splicing (40,41).
Together these data suggest that alternative splicing
could play an important role in P. falciparum.
Overview of P. falciparum RNA-Seq data sets
To investigate splicing in P. falciparum on a transcriptome-
wide scale, we generated short read RNA-Seq data from
multiple timepoints of a highly synchronous, large-scale,
intraerythrocytic culture and analyzed these data, in con-
junction with publically available data sets, for splice junc-
tions. To guarantee adequate representation of distinct
blood stages, timepoints were collected from the 3D7
Oxford culture approximately 11 (ring), 22 (trophozoite),
33 (late trophozoite/early schizont) and 44 (late schizont) h
post-invasion. After total RNA isolation, poly-A RNA
was purified and prepared for Illumina sequencing using
the Long March protocol (27). All primary sequencing
data can be found in the NCBI Short Read Archive
under accession number SRA024324.1. To maximize
our transcriptome-wide examination of splicing, we also
included two previously published P. falciparum RNA-
Seq data sets in our analysis: one from seven time-
points within the blood stage of 3D7 parasites by Otto
et al. (14) and one from the late schizont timepoint of our
experiment (27).
We aggregated these data and after preliminary filtering
and sequence collapsing, ran two analyses in parallel: a
Bowtie/BLAT (31,32) pipeline to align ungapped reads
back to the P. falciparum genome (PlasmoDBv6.3) and
HMMSplicer v0.7.0 (28) to detect and score exon–exon
splice junctions. The Bowtie/BLAT pipeline was able
to align between 84 and194 million bases of sequence to
the P. falciparum genome for each independent
timepoint (Supplementary Table S2) for a total of over
1.5 billion aligned bases. Discounting antigenic variation
gene families (272 vars, rifins and stevors), each exonic
nucleotide of a gene was covered by a median of 59
reads. HMMSplicer was also run on the data set with a
minimum intron size of 5 bp and a maximum intron size
of 1000 bp, covering 99.6% of all annotated P. falciparum
introns. More than 1.9 million reads in the combined
data set were mapped to junctions (Supplementary
Table S4).
To gauge the quality of the junctions predicted from the
combined data set, we examined the distribution of
HMMSplicer scores calculated for all predicted 50
GU-AG 30 junctions (Figure 1A). HMMSplicer scores
reflect both the strength of the junction alignment and
the cumulative support for that junction within the data
set (28). The distribution of HMMSplicer scores for ca-
nonical P. falciparum junctions is clearly bimodal, perhaps
indicating predictions of differing reliability. In this
organism, PlasmoDB gene models and ESTs provide a
set of previously known splice junctions that are likely
to be valid (12,30,43,44) and the distribution of
HMMSplicer scores for only those junctions with
boundaries matching previously known junctions was
found to primarily fall within the higher scoring popula-
tion. Therefore, an HMMSplicer score of 1075, represent-
ing the natural breakpoint in the bimodal distribution,
was chosen as an operational threshold for subsequent
analysis (Figure 1A). Below this threshold, support for
detected junctions decreases rapidly, and thus the false
positive rate among these lower-confidence junctions is
likely to be higher. However, 13% of all known junctions
detected within the combined data set fall below our
threshold, indicating the presence of valid junctions with
non-ideal coverage, though only 0.1% score below 600
(Figure 1A). While we have enacted an operational thresh-
old, all HMMSplicer junctions regardless of score are ac-
cessible for additional analyses (Supplementary Files S1
and S2, upload at http://plasmodb.org/cgi-bin/gbrowse/
plasmodb/).
HMMSplicer analysis of RNA-Seq data reveals new
canonical splice junctions
HMMSplicer found 7655 50 GU-AG 30 junctions above the
operational threshold within the combined RNA-Seq data.
More than 88% were supported by reads from both time
courses. Of these high scoring junctions, 6678 (87.2%)
confirm introns in PlasmoDB gene models or ESTs
(Supplementary File S3, upload at http://plasmodb.org/
cgi-bin/gbrowse/plasmodb/). 977 (12.8%) support new
introns, an increase of 11% over the current genome anno-
tation (Figure 1B, Supplementary File S4, upload at http://
plasmodb.org/cgi-bin/gbrowse/plasmodb/). 431 (43.9%)
of these new junctions fall either totally or partially
outside of annotated gene models, suggesting splicing in
unannotated untranslated regions (UTRs) or in
unannotated genes, whereas 544 (55.4%) align within
gene models. As discussed below, many of the new junc-
tions discovered within gene models represent alternative
3824 Nucleic Acids Research, 2011, Vol. 39, No. 9
transcript isoforms or splicing of antisense transcripts.
Unexpectedly, 2 (0.2%) new junctions map to neighboring
genes encoded on opposite strands, suggesting
unannotated overlap between these gene pairs.
We sought to lend support to the new 50 GU-AG 30
junctions detected by HMMSplicer by calculating
WebLogos (45) from their 50- and 30-splice sites. If these
new junctions represent true splicing events, they would be
predicted to recapitulate the nucleotide preferences found
within 50- and 30-splice sites of known 50 GU-AG 30 junc-
tions. Indeed, no significant differences were observed
between our calculated sequence logos for PlasmoDB/
EST matching junctions versus new junctions, and both
sets of logos closely matched previously published results
(Figure 1C) (7). In contrast, logos produced from the
bottom 10% of new junctions below the operational
threshold contained little information other than their 50
GU-AG 30 boundaries (Supplementary Figure S3A).
Efforts to determine a branchpoint motif from the
introns defined by our high-scoring canonical junctions
yielded no convincing results, similar to Chakrabarti
et al.’s efforts to determine a branch point motif from a
smaller set of EST introns (7).
The validity of new 50 GU-AG 30 junctions was also
independently assessed by experimental validation using
an biological replicate of our original blood stage
timecourse and the strategy described in Figure 2A.
Twelve 50-alternate splice sites, 2 30-alternate splice sites,
17 skipped exons and 10 spliced antisense transcripts were
tested (Table 2, Supplementary Figure S1C and D). A
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total of 19/21 (90.5%) new splicing events ranging in score
from 1189.3 to 1544.2 were experimentally confirmed,
including a skipped exon in MAL13P1.159 (thioredoxin)
and splicing of an antisense transcript mapping to
PFF0290w (long chain polyunsaturated fatty acid elong-
ation enzyme) (Figure 2B and C); 13/20 (65%) events
below the operational threshold with scores ranging
from 984.6 to 1050.5 were also confirmed. Since more
than half of these lower scoring events were successfully
verified, these validations also confirm that our threshold
is conservative—in addition to excluding false positive
junctions, it also excludes some true splicing events, such
as the 30-alternate splice site in PFB0279w (conserved
Plasmodium protein, Figure 2D). Overall, these results
indicate that a high percentage of new junctions both
above and below the threshold are genuine, although
independent confirmation may be required for lower
scoring junctions.
Our results suggest both that a number of true positive
junctions exist below our operational threshold and that
the nucleotide preferences present at the 50- and 30-splice
sites of known junctions do not hold for the lowest
scoring, least reliable junctions in the data set.
Therefore, to attempt recovery of true 50 GU-AG 30 junc-
tions below our operational threshold, an orthogonal
score based on position specific scoring matrices (46) of
the splice site logos was evaluated. Although this type
of motif scoring ultimately lacked sufficient information
for large-scale computational rescue (Supplementary
Figure S3B), it could potentially be used to prioritize ex-
perimental assessment of new junctions (Supplementary
File S5).
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Figure 2. Validation of new splicing events. (A) Shade indicates the relative abundance of each isoform. Initial outer PCR (green arrows) amplifies
both isoforms from cDNA. A restriction enzyme then cuts the known isoform. Nested inner PCR (blue arrows) amplifies only the uncut, new
isoform, which is then sequence confirmed. Gbrowse (66) windows depict validation of a skipped exon in MAL13P1.159 (B), an antisense junction in
PFF0290w (C), and an alternate 30-splice site in PFB0279w (D). All HMMSplicer junctions scoring higher than 980 are shown as either dark blue
bars (known junctions) or light blue bars (new conflicting junctions). The number of reads supporting each junction is shown in the bars, while the
direction of the arrow reflects the direction of the splice sites. Validation sequencing results are shown in magenta. Bowtie coverage for each
nucleotide in the window is shown as a histogram. Underneath, the dark blue bars depict PlasmoDB v6.3 gene models with numbers denoting
the exons, while the gold bars at the bottom of each window depict ESTs.
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Inspection of non-canonical splice junctions reveals new 50
GC-AG 30 junctions
In many eukaryotes, splicing occasionally occurs at non-50
GU-AG 30 boundaries, sometimes via the major U2-type
spliceosome as with 50 GC-AG 30 introns (47), or via the
minor U12-type spliceosome as with 50 AT-AC 30 introns
(48), or spliceosome-independently as with the 50 CA-AG
30 intron in yeast HAC1 (49). The presence of 50 GC-AG 30
junctions in P. falciparum ESTs and gene models (12,13)
suggests that the parasite uses 50 GC non-canonical splice
sites, yet this likelihood has never been examined in detail.
Of the 984 non-canonical junctions above our operational
threshold (Supplementary File S6, upload at http://
plasmodb.org/cgi-bin/gbrowse/plasmodb/), 12 map to 50
GC-AG 30 boundaries (Supplementary Table S5). Of
these, 7 were supported by either EST evidence or
annotated PlasmoDB gene models, and 5 were completely
new. We used WebLogo v3.0 to construct 50- and 30-splice
site sequence logos from all 12 50 GC-AG 30 junctions (45)
(Figure 3). The 30-splice site logo was very similar to the
Table 2. Verification of new junctions in conflict with known junctions
Gene name PlasmoDBv6.3 description Score Validated Type Frame-shift? Isoform
difference
in bp (aa)
R T LT/ES S
PFL1810w Conserved Plasmodium protein 1544.2 Yes 50ss Yes 131 11 8 11 5
1283.2 Yes 50ss Yes 218 3 0 3 1
PFE0390w Conserved Plasmodium protein 1422.1 Yes 50ss Yes 65 13 10 8 3
PF13_0138 MSF-1 like protein 1372 Yes 50ss Yes 55 7 5 3 7
PFI0400c Conserved Plasmodium membrane
protein
1369.8 Yes Exon skip No 126 (42) 2 1 19 1
PFF0290w Long chain polyunsaturated fatty
acid elongation enzyme
1291.8 Yes Antisense – N/A 9 6 14 5
MAL13P1.225 Thioredoxin 1277.3 Yes Exon skip Yes 34 2 6 0 0
PFE0055c Heat shock protein 1275.4 Yes 50ss No 36 (12) 54 14 3 8
MAL8P1.126 Serine protease 1257.4 Yes 50ss Yes 109 1 1 11 8
PF10_0025 PF70 protein 1256.8 Yes 50ss Yes 74 18 2 0 0
PFD1050w Alpha-tubulin II 1243.2 – Antisense – N/A 1 0 5 1
MAL13P1.159a Thioredoxin 1239.9 Yes Exon skip No 33 (11) 0 1 0 3
PFC0780w Cleavage and polyadenylation
specific factor
1231.7 – Antisense – N/A 2 6 27 8
PFD0775c RNA binding protein 1228.4 Yes Antisense – N/A 1 6 8 0
PF10_0194 NoOP12-like protein 1219.4 Yes Exon skip Yes 41 1 0 0 1
PFL1440c Conserved Plasmodium protein 1217.6 Yes Exon skip No 57 (19) 0 2 0 1
PF11_0291 Conserved Plasmodium protein 1203.5 Yes 50ss No 39 (13) 1 0 0 5
PFC0360w Activator of HSP90 ATPase
homolog 1-like protein
1200.5 Yes Exon skip Yes 223 1 1 3 0
PFC0495w Plasmepsin VI 1192.6 Yes Antisense – N/A 0 0 8 3
PF14_0394 Conserved Plasmodium protein 1190 Yes 50ss Yes 98 2 4 5 0
MAL13P1.146 AMP deaminase 1189.3 Yes antisense – N/A 1 1 0 0
PF11_0379 Conserved Plasmodium protein 1050.5 Yes Exon skip No 60 (20) 1 0 0 1
PFL1445w Conserved Plasmodium protein 1041.3 Yes Exon skip Yes 85 0 6 0 0
MAL13P1.16 SNARE protein 1034.7 Yes Exon skip No 108 (36) 0 0 0 4
MAL13P1.277 DNAJ-like protein 1034.2 Yes Exon skip Yes 146 2 0 3 0
PFF1210w Phosphatidic acid phosphatase 1032.4 Yes 50ss No 66 (22) 2 0 3 5
PFB0600c Conserved Plasmodium protein 1026.1 Yes Antisense – N/A 1 1 3 0
PF14_0128 Ubiquitin conjugating enzyme 1018.5 Yes Exon skip Yes 104 0 1 3 0
PF14_0316 DNA topoisomerase II 1011.4 – 50ss No 459 (153) 0 0 3 1
PFB0279wa Conserved Plasmodium protein 1010.9 Yes 30ss Yes 97 1 4 3 0
PFL1465c Heat shock protein hslv 1004.5 – Exon skip Yes 40 0 2 0 4
PF10_0372 Antigen UB05 1004.4 – antisense – N/A 0 1 0 1
PF11_0182 Conserved Plasmodium protein 1004.1 Yes Exon skip Yes 56 0 0 5 0
PFF0365c G-protein associated signal
transduction protein
996.3 – Exon skip Yes 163 2 0 0 0
PFB0445c DEAD box helicase, UAP56 995.9 – 30ss Yes 74 1 0 0 0
PFD0895c Bet3 transport protein 991 – Antisense – N/A 0 0 2 0
PF10_0116 Conserved Plasmodium protein 989.9 Yes 50ss Yes 74 0 0 2 0
PF14_0604 Conserved Plasmodium protein 988.1 Yes Exon skip Yes 344 1 0 0 0
PFI0560c Conserved Plasmodium protein 987.7 Yes Exon skip Yes 40 1 0 0 2
PFB0550w Peptide chain release factor
subunit 1
985.5 – Exon skip Yes 155 0 0 2 0
PF11_0355 Conserved Plasmodium protein 984.6 Yes Antisense – N/A 1 1 0 0
Conflicts are ranked by lowest HMMSplicer score within the pair, and the black line denotes the operating HMMSplicer threshold of 1075.
aValidations shown in more detail in Figure 2. For all conflict types except antisense, the new junction was evaluated for maintenance of the
ORF—nucleotide and amino acid (if applicable) differences between new and known isoforms are listed. Read counts for new junctions (normalized
by the number of reads mapped by Bowtie for each timepoint) are listed for ring [R, (TP1, TP0, TP8)], troph [T, (TP2, TP16, TP24)], late troph/early
schizont [LT/ES, (TP3, TP32)] and schizont [S, (TP4, TP40, TP48)] timepoints.
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canonical 30-splice site logo. However, several clear differ-
ences distinguished the 50-splice site logo for 50 GC-AG 30
junctions from that of canonical junctions. Whereas ca-
nonical P. falciparum 50-splice sites have a slight prefer-
ence for AG as the last two bases of the 50-exon, all 12 50
GC-AG 30 examples contain AG in these positions, and all
12 also contain an A at the third position of the intron.
These same 3 nt are also present in the two PlasmoDB 50
GC-AG 30 junctions with HMMSplicer scores below our
operational threshold. Both the fourth and fifth positions
of 50 GC-AG 30 introns also appear to have strong,
although not absolute, nucleotide preferences. Though
stronger contextual sequence may simply reflect the
small number of input sequences, stronger consensus
50-splice site motifs have been documented for 50
GC-AG 30 introns in other organisms as well (11). As
with 50 GU-AG 30 introns, efforts to determine a
branchpoint motif from these introns failed to produce
any convincing results.
We also considered the possibility that the parasite
might employ splice sites other than 50 GU-AG 30 and 50
GC-AG 30. However, preliminary manual inspection of
the remaining non-canonical junctions revealed that
many of them were likely to be false positives caused by
read errors. Polymerase slipping, template switching, and
single base pair substitutions are well-documented phe-
nomena (50–52) that can occur during both the reverse
transcription and PCR steps of library preparation.
These upstream errors have no associated cost in
sequence quality, and therefore may explain the origins
of high scoring, erroneous junction reads. Since the prob-
ability of an erroneous read mapping to non-canonical
boundaries is much greater than the probability of it
mapping to canonical boundaries, it is not surprising
that the false positive rate within the non-canonical junc-
tions is higher than within the canonical junctions.
Two additional filters designed to eliminate false
positive junctions while retaining any potential true non-
canonical junctions were applied to the non-canonical
junctions (Supplementary Materials and Methods). Since
HMMSplicer is more sensitive to errors the closer they are
to the true breakpoint of a junction read (28), the first
filter eliminated non-canonical junctions with single base
substitutions within 15 bp of either inner edge that caused
miscalling of the junction breakpoint (343 of 972 junc-
tions). The second filter removed non-canonical junctions
in very highly covered regions since the probability of
error creation during preparation and sequencing in-
creases as the copy number for a given sequence increases
(356 of 629 remaining junctions). As an internal check,
neither filter eliminated any of the 12 50 GC-AG 30 junc-
tions previously identified.
Manual inspection of the remaining 273 non-canonical
junctions yielded no additional, credible non-canonical
splice junctions. Although 50 AT-AC 30 splice sites have
been observed in introns excised by the U12 minor
spliceosome (48), failure to detect any in the RNA-Seq
data is consistent with our failure to find P. falciparum
homologs to proteins specific to the human U12-type
spliceosome (53). Similarly, a previous search by Lopez
et al. for all snRNAs in a variety of eukaryotes returned
no minor spliceosome snRNAs in any Apicomplexa,
including the two rodent Plasmodium species examined
(54). Together, these results indicate that P. falciparum is
unlikely to possess a minor U12-type spliceosome.
Genome-wide characterization of alternative splicing
Alternative splicing increases transcriptome complexity by
generating multiple isoforms from the same precursor that
differ in single 50- or 30-splice sites or in whole exons and
introns. To find alternative splicing within the combined
data set in an unbiased manner, independent of gene
models, high scoring canonical and 50 GC-AG 30 junctions
were compared to each other in a pair wise manner. To be
considered ‘conflicting junctions’, one of the inner edges of
a junction must have aligned within the intronic area of
the other junction (Supplementary Figure S1B). Since
direct counting of these occurrences would over-inflate
the number of alternative splicing events (for example, a
single skipped exon event would count as two pair-wise
conflicts), conflicts were further aggregated into junction
groups (Supplementary Figure S1B), which were then
divided by strand orientation where applicable
(Supplementary File S7). In total, 196 (48.3%) alternate
50-splice sites, 145 (35.7%) alternate 30-splice sites, 8
(2.0%) mutually exclusive alternate 50- and 30-splice sites
and 56 (13.8%) skipped exons were tallied (Figure 4A).
The majority of alternative splicing events occurred in
gene models in the sense direction, though some
also occurred outside of gene models. These intergenic
events most likely indicate alternative splicing in
unannotated P. falciparum UTRs or in unannotated
genes. Interestingly, all four types of alternative splicing
were also seen in antisense junction groups. Further
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analysis of antisense splicing events is discussed in the next
section.
Because the combined RNA-Seq data are comprised of
short reads rather than full length mRNAs, the collection
of splice junctions that compose a given isoform is difficult
to resolve, and thus the exact number of isoforms encoded
by the alternative splicing events described here could not
be determined. However, transcriptome-wide, the
combined data set supports the existence of between 279
and 369 alternative isoforms (533 and 623 total isoforms)
for the 254 genes in which conflicting junctions were
detected (Supplementary File S7). Alternative splicing
events for most genes maximally support between 2 and
4 isoforms. However, a handful of genes [PF14_0338
(conserved Plasmodium protein), PFF0630c (conserved
Plasmodium protein), PFL1440c (conserved Plasmodium
protein), PFC0495w (plasmepsin VI), and PFC0912w
(signal peptidase)] could encode up to 8–16 different
isoforms. In addition to supporting up to 8 sense
isoforms, an overlapping antisense junction was also
validated for PFC0495w (plasmepsin VI), making it par-
ticularly interesting (Table 2). Gene ontology (GO)
analysis of alternatively spliced genes did not reveal any
functional patterns (Supplementary Materials and
Methods).
The transcriptome complexity afforded by alternative
splicing often increases the number of distinct proteins
encoded by an organism. Of the 310 P. falciparum alter-
native splicing events mapped to gene models in the sense
direction, 10% are predicted to produce altered UTRs,
while the remaining 279 (90%) are predicted to produce
distinct coding sequences. Of these, close to one third
maintain coding frame, either adding or removing amino
acids from the predicted protein (Figure 4B). In contrast,
the majority of alternative splicing events result in frame-
shifts, most of which introduce premature termination
codons within the gene model’s predicted coding sequence.
One explanation for the abundance of protein
truncating alternative splicing events in P. falcparum is
that these transcripts may not be translated, but instead
could be intermediates bound for non-sense-mediated
decay (NMD). Regulated splicing controlling the ratio
of NMD-targeted to protein-coding isoform produced
from certain genes is a mechanism of post-transcriptional
regulation in other organisms (39,55). However, NMD
has not been shown to exist in the parasite. Using
human and yeast sequences for the core conserved
NMD surveillance proteins, UPF1, UPF2 and UPF3
(paralogs UPF3a and UPF3b in humans) (56), best recip-
rocal hits analysis was able to find homologs to all three in
P. falciparum, suggesting the NMD pathway exists in this
parasite (Table 1). While it is unclear what the trigger for
NMD may be in P. falciparum, 119 (73%) of the 162
truncating events do so >50 bp upstream of the last
splice junction, rendering them eligible for NMD in mam-
malian systems (56). Regardless, our results suggest that
the majority of alternative splicing events in the blood
stages of P. falciparum either produce truncated protein
isoforms or tune gene expression post-transcriptionally.
We also looked at the relative abundance of alternate
junctions in comparison to their recovered gene model
counterparts (Figure 4C). Many occurred at <10% of
the frequency of the conflicting gene model junction
within the combined data sets, and may correspond to
isoforms either targeted for non-sense-mediated decay or
of minimal use in the blood stages. Interestingly, 33 alter-
native junctions occurred at 100% of the frequency of
their conflicting gene model counterparts, indicating
that the gene model isoform of the transcript may not
be the dominant blood stage isoform (Supplementary
Table S6).
A minority of introns are poorly spliced in P. falciparum
Previous reports of alternative splicing in P. falciparum
have noted instances of transcripts with retained introns
(12), and regulated splicing efficiency can control such im-
portant biology as onset of meiosis in S. cerevisiae (57).
Therefore, to gauge general splicing efficiency as well as to
discover poorly spliced outlier introns, we calculated the
ratio of junction reads to the average number of reads
covering both cognate exon–intron borders (58). Only re-
covered gene model junctions in genes without mapped
antisense junctions were considered to avoid complicating
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factors. Because the data sets analyzed here were not
generated specifically for the purpose of analyzing
splicing efficiency, calculations could be made for only a
subset of splice junctions in which the read counts
covering both exon–intron borders were relatively
similar (Supplementary Materials and Methods). For the
779 introns analyzed, junction reads were recovered a
median of five times more often than exon–intron reads
(Supplementary File S8). However, 44 (5.6%) analyzed
introns appear to be very poorly spliced in the blood
stages as they are retained in at least 50% of the tran-
scripts sampled here.
A subset of new junctions within genes challenge their
corresponding gene models
Although gene models were not consulted during detec-
tion of junctions or alternative splicing, we assessed how
thoroughly they were encompassed by our results. Of the
8435 predicted splice junctions in PlasmoDB v6.3 gene
models, 1103 were not observed in the combined data
set, even below our operational threshold. Gene models
with unrecovered splice junctions had a median coverage
of six reads per coding nucleotide, indicating that in
general, these genes were not substantially expressed
during the blood stages. However, for 50 unrecovered
known junctions, new junctions above the operational
threshold were observed that did not match the
boundaries indicated by the gene model (Supplementary
Table S7). Although it is possible that the gene model
isoforms are not expressed in the blood stages in these
cases and that the new junctions represent blood
stage-specific alternate isoforms, it is more likely that the
corresponding gene models are incorrect.
Genome-wide characterization of antisense splicing
While probing for conflicting junctions, we noticed a class
of conflicts in which one junction contained intron
boundaries on a given strand while the other mapped to
intron boundaries on the opposite strand (Supplementary
Figure S1D). Although none of the data sets analyzed here
were derived from a directional library, the orientation of
intron boundaries has been used in the past to assign dir-
ection to ESTs (59). In addition, antisense transcription
has been previously noted in P. falciparum (60), and ESTs
antisense to gene models have also been documented (12).
Therefore, it is likely that these ‘antisense conflicts’ derive
from overlap of two spliced transcripts transcribed in
opposite directions.
To expand on the initial discovery of antisense conflicts,
we searched for all high scoring junctions with at least one
intron boundary antisense to an annotated gene model.
This analysis differed from the conflicting junctions
analysis in two important ways. First, it incorporated anti-
sense junctions that do not conflict with any sense introns
(Supplementary Figure S1D). Second, it excluded anti-
sense conflicts between junctions in which neither
mapped to a gene model (four independent conflicts),
and thus neither could be deemed ‘sense’ or ‘antisense’.
In total, this list contains 200 antisense junctions
mapping to 149 gene models (Supplementary File S9).
In addition, antisense junctions overlapping 16 of these
genes appear to undergo alternative splicing to produce
between 38 and 59 different isoforms (example shown in
Figure 5A, Supplementary File S7). Weblogos of the 50-
and 30-splice sites of antisense junctions revealed no sig-
nificant differences compared to known junctions (Figure
5B), suggesting that antisense junctions arise from the
same mechanism as other splice junctions in the transcrip-
tome. No GO terms were significantly enriched within
genes with mapped antisense junctions (Supplementary
Materials and Methods).
Antisense junctions could derive from either overlap
between neighboring gene models encoded on opposite
strands of the genome or from unannotated transcripts
antisense to gene models. Indeed, 23 antisense junctions
could be attributed to overlap between 15 pairs of neigh-
boring annotated genes on opposite strands based on
linking junctions or ESTs (Supplementary Table S8).
Only one gene pair (PFE1425c/PFE1420w) is annotated
as overlapping, while nine had prior EST evidence of
overlap. The remaining five pairs had no prior evidence
of overlap. Twelve pairs were arranged in a tail-to-tail
(overlapping 30-ends) fashion, while three were arranged
in a head-to-head (overlapping 50-ends) fashion. Several
studies have reported a bias toward tail-to-tail overlaps
in mammalian genomes (61), although others refute this
assertion (23).
Overlap between annotated genes, however, could not
explain all antisense junctions observed in the RNA-Seq
data. Of the 177 antisense junctions without direct
evidence of neighboring gene overlap, 49 map to genes
where neighbors on either side are on the same strand.
This observation argues strongly for the presence of
unannotated transcripts overlapping annotated genes in
an antisense manner. We further investigated whether
these 177 antisense junctions might belong to coding or
non-coding transcripts. Genomic sequence 300 nt
upstream and downstream of each junction was merged
and translated in all three frames, and the length of the
longest open reading frame (ORF) that crossed the
junction was assessed. Of 177 junctions, only 16
occurred in an ORF greater than 300 bases long
(average exon size in intron-containing genes is 552
bases). It is possible that these antisense junctions
connect shorter than average exons, or occur in UTR
regions of unannotated genes. It is also possible that
many of them belong to non-coding transcripts. Further
elucidation of the structure of these antisense transcripts is
necessary to determine their primary function.
Interestingly, over 86% of antisense junctions map to
intron-containing genes, though only slightly more than
half of genes in P. falciparum contain introns. This bias is
significant, with a binomial probability of 3e24. A
similar bias was seen in Arabidopsis thaliana in tail-to-tail
overlapping transcripts (22), and could be explained by
preferential overlap between introns in antisense tran-
scripts and introns in sense transcripts (Supplementary
Figure S1D). In some cases, multiple antisense introns
overlap extensively with multiple sense gene introns in
the same gene model, but not with more expansive exon
regions (Figure 5A). The observed distribution of overlap
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with sense introns is highly statistically significant (P-value
of chi-squared test <0.001) when compared to the
expected distribution from random re-placement of anti-
sense junctions within their associated genes (Figure 5C).
This expected distribution was calculated by first
determining the probability of encountering a GU
(50-splice site) or an AG (30-splice site) on the opposite
strand of introns versus exons within the group of genes
with mapped antisense junctions. These probabilities then
guided otherwise random re-placement of each antisense
junction within its corresponding gene model, keeping the
original length of the antisense intron intact. After
re-placement, the distribution of overlaps for simulated
antisense introns with sense introns was tallied. This
re-placement was iterated 100 times, with the mean
percent of nucleotide overlap with sense introns± stand-
ard deviation shown. Thus antisense introns appear to not
only overlap intron-containing sense genes significantly
more often than expected, but also overlap the intron
portions of sense genes significantly more than expected.
DISCUSSION
Completion and preliminary annotation of the P. falcip-
arum genome in 2002 facilitated a series of large-scale ex-
periments designed to illuminate the parasite’s biology on
a genomic-, transcriptomic- or proteomic-wide level. In
pursuit of a thorough understanding of P. falciparum
blood stage genetic regulation, steady-state gene expres-
sion experiments captured its unique, cascade-like tran-
scriptome (1,2). Subsequent genome-wide RNA decay
experiments revealed global rapid turn over of RNA in
the early hours post-invasion, and then progressively
longer transcript half-lives during the remainder of the
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blood stage cycle (62). The new splicing events described
here reveal additional complexities within the transcrip-
tome not captured by these previous studies, such as al-
ternative splicing, gene overlap and spliced antisense
transcripts, and thus, the present study fits into a larger,
more dynamic understanding of the transcriptome of
P. falciparum.
Traditionally, full-length cDNA and EST data have
been used for analysis of transcript structure and
variants. EST collections in P. falciparum have indeed
produced increasingly accurate gene models (12,13,43,44).
However, no full-length cDNA sequences have been
published for P. falciparum, and many gene models lack
or are incompletely covered by ESTs. RNA-Seq provides
the advantage of capturing an entire transcriptome at great
depth, enabling detection of low copy number transcripts
and variants. However, in its current form, RNA-Seq
cannot capture a single transcript molecule from beginning
to end. Despite this limitation, the orders-of-magnitude
increase in throughput over EST libraries expanded the
repertoire of splice junctions known in the parasite by
>11% in the present study.
The ability to accurately and sensitively map junction
reads from the RNA-Seq data sets proved crucial to our
analysis. For this purpose, we used HMMSplicer, an al-
gorithm we developed specifically to overcome the chal-
lenges presented by RNA-Seq data and the inherent biases
within the P. falciparum genome (28). In contrast to
previous RNA-Seq studies in P. falciparum and other or-
ganisms (14,63), we relied only on alignment of junction
reads within the genome to detect splice junctions, rather
than depending on gene models or ungapped read
coverage. Also, HMMSplicer does not use additional as-
sumptions to filter its output junction set, instead scoring
each splice junction on the strength of supporting reads.
Because a low false positive rate was desired for accurate
characterization of splicing in P. falciparum, we estab-
lished an operational HMMSplicer score threshold
based on the bimodal distribution of known versus
new canonical splice junctions. However, setting this
threshold held the disadvantage of excluding some
known junctions, and therefore some true new junctions
as well. Indeed, our biologically independent validation
experiments demonstrated that even lower scoring junc-
tions were more likely than not to represent true splicing
events. Although these lower scoring junctions were
excluded from downstream analysis in the present study,
they remain accessible in the HMMSplicer results
(Supplementary Files S1 and S2, upload at http://
plasmodb.org/cgi-bin/gbrowse/plasmodb/).
We also did not rely on gene models during discovery of
alternative splicing. This decision was prompted by several
observations within the data. First, there were ambiguous
instances in which a junction conflicted with a gene model,
but the gene model junction was not recovered within the
data set. These instances could potentially represent gene
model errors, making it inappropriate to classify them as
alternative splicing without additional data. Conversely,
areas of the transcriptome with no gene model contained
multiple junctions that could not possibly exist within the
same transcript (Figure 4A). These intergenic junction
groups clearly exhibit alternative splicing and would
have been missed by reliance on gene models. Thus our
unbiased approach allowed for more accurate and sensi-
tive detection of alternative splicing events based solely on
experimental observation of the conflicting junctions
themselves.
Although P. falciparum ESTs and even some gene
models include non-canonical 50 GC-AG 30 splice junc-
tions, to our knowledge, no study has attempted to
identify or characterize non-canonical junctions in
P. falciparum. We found 12 high scoring 50 GC-AG 30
junctions within the non-canonical junctions results, 5 of
which were new. As in other organisms, the 50-splice site
for these junctions has a remarkably high information
content compared to the 50-splice site for canonical
P. falciparum junctions, perhaps indicating greater
reliance on sequence context for recognition of 50 GC
splice sites. In particular, the strong preference for G at
the fifth position in 50 GC-AG 30 introns is interesting.
Although G is strongly preferred at this position in
human canonical introns (11), and mutation of this G
to other bases reduces splicing fidelity in yeast (64),
P. falciparum canonical introns have almost no base pref-
erence at this position (Figure 1C) (7). At present, it is
unclear how complete the list of 50 GC-AG 30 junctions
is, given that the percent of splice junctions mapping to
those splice sites (0.1%) remains several fold lower in
P. falciparum than in other organisms (11). In addition,
although filters designed to aid discovery of any additional
non-canonical junctions were implemented, manual
inspection found no convincing examples. It is possible
that despite efforts to limit bias, the filters inadvertently
eliminated true positive junctions or manual inspection
failed to detect credible non- 50 GU-AG 30 or 50 GC-AG
30 junctions within the data.
Our analysis uncovered not only constitutive and alter-
native splicing in P. falciparum, but also complex tran-
scriptional arrangements in the parasite. Independent
validation of new junctions antisense to sense junctions
indicates that these are not artifacts of the RNA-Seq tech-
nique. Rather, antisense junctions in the data suggest
overlap between annotated sense genes and antisense
transcripts, some of which appear to be extensions of
neighboring annotated genes, while others are likely
unannotated. For unknown reasons, antisense splice junc-
tions tend to encompass sense introns more than would be
expected by chance. It is unknown if this phenomenon is
specific to P. falciparum antisense splice junctions, as it has
not been explored in other organisms to our knowledge.
Perhaps antisense introns must be spliced out in approxi-
mately the same area as sense introns to allow tran-
script pairs to physically interact with one another.
Conversely, if the low complexity sequence that comprises
P. falciparum introns generally does not encode useful
information on either strand, it would have to be
removed from both sense and antisense transcripts to
preserve function. Further inquiry is necessary to distin-
guish between these hypotheses.
The larger impact of the transcriptome features re-
vealed by the new canonical and 50 GC-AG 30 junctions
captured here remains unknown. Consistent with reports
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correlating alternative splicing prevalence with organismal
complexity (65), alternative splicing events do not appear
to be widespread in P. falciparum blood stages, affecting
8.6% of intron-containing genes. Although relatively
scarce, alternative splicing events in P. falciparum may
expand important protein functionalities in the organism
and may also contribute to crucial post-transcriptional
gene regulation—however, it is possible that their impact
on parasite biology is minimal. Interestingly, these events
appear to occur with almost no pressure to preserve
ORFs, as only one-third are predicted to do so, the
same proportion expected by chance. We have suggested
that alternative splicing events predicted to result in
truncated ORFs may be linked to a NMD system in the
parasite as a means of gene regulation. It would be inter-
esting to determine if such isoforms decay faster than their
corresponding protein-coding isoforms, perhaps by ex-
tending previous methods for determining RNA decay
rates in P. falciparum using high-throughput sequencing.
Unfortunately, current RNA decay data in P. falciparum
does not allow for discrimination between the decay rates
of isoforms of the same transcript (62). The observed
overlap between sense and antisense transcript pairs of
may also contribute to important gene regulation in the
parasite by a variety of mechanisms (24). In addition,
unannotated antisense transcripts could perform a
variety of as-yet-unknown functions that may or may
not be restricted to regulation of their sense partners.
Unraveling these possibilities in both the symptomatic
blood stages of P. falciparum as well as in the organism’s
larger lifecycle will provide an unprecedented understand-
ing of a deadly human pathogen.
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